Neuronetics Partners with Transformations Care Network to Expand Availability of NeuroStar TMS Equipment
Neuronetics, a medical technology company specializing in products for neurohealth disorders, has recently announced an exclusive partnership with Transformations Care Network (TCN), one of the largest mental health care providers in the country. This partnership aims to increase the availability of transcranial magnetic stimulation (TMS) equipment to patients by making Neuronetics the sole supplier of new NeuroStar TMS devices to TCN.
As part of the agreement, Neuronetics will expand its NeuroStar TMS footprint within TCN, allowing more patients to benefit from this innovative treatment option. TMS is a non-invasive procedure that uses magnetic fields to stimulate targeted areas of the brain, providing relief for individuals suffering from various neurological conditions.
By becoming TCN’s exclusive supplier, Neuronetics solidifies its position as a leading provider of TMS equipment in the mental health care sector. The partnership not only enhances Neuronetics’ reputation but also enables TCN to offer its patients advanced treatment options for neurohealth disorders.
Neuronetics has gained recognition for its commitment to developing and marketing products that significantly improve the quality of life for those living with neurohealth disorders. Their NeuroStar TMS technology has been clinically proven to effectively treat conditions such as major depressive disorder and obsessive-compulsive disorder, while also maintaining a strong safety profile.
Transformations Care Network, on the other hand, serves as a prominent mental health care provider, offering a range of services that cater to the diverse needs of patients across the country. By collaborating with Neuronetics, TCN demonstrates its dedication to providing cutting-edge treatment solutions and expanding access to innovative technologies.
This exclusive partnership between Neuronetics and Transformations Care Network highlights both companies’ shared goal of improving patient outcomes and advancing the field of mental health care. The expanded availability of NeuroStar TMS equipment through TCN will undoubtedly benefit individuals seeking effective neurohealth disorder treatments.
In conclusion, Neuronetics’ extended commercial partnership with Transformations Care Network represents a significant step towards enhancing the provision of TMS equipment and expanding treatment options for patients with neurohealth disorders. This collaboration reinforces both companies’ commitment to innovation and signifies a positive development for the mental health care sector.
Comments